Evaluation of blood biomarkers related to interindividual difference in pharmacokinetics and clinical effects of tolvaptan enantiomers and their metabolites in heart failure patients
Not Applicable
Recruiting
- Conditions
- heart failure
- Registration Number
- JPRN-UMIN000041334
- Lead Sponsor
- Department of Hospital pharmacy Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients discontinuing tolvaptan 2. Patients who are judged by physicians as inappropriate for study enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method